سامانه مدیریت نشریات علمی دانشگاه علوم پزشکی مشهد

علیزاده, لیلا, کشاورز, دکتر زهره, شالباف, دکتر احمد, ایرانپور, دکتر سهراب. (1403). چالش‌ها و موانع واکسیناسیون ویروس پاپیلومای انسانی در زنان سنین باروری بر مبنای مدل اعتقاد بهداشتی؛ مروری سیستماتیک. , 27(8), 64-80. doi: 10.22038/ijogi.2024.79736.6083
لیلا علیزاده; دکتر زهره کشاورز; دکتر احمد شالباف; دکتر سهراب ایرانپور. "چالش‌ها و موانع واکسیناسیون ویروس پاپیلومای انسانی در زنان سنین باروری بر مبنای مدل اعتقاد بهداشتی؛ مروری سیستماتیک". , 27, 8, 1403, 64-80. doi: 10.22038/ijogi.2024.79736.6083
علیزاده, لیلا, کشاورز, دکتر زهره, شالباف, دکتر احمد, ایرانپور, دکتر سهراب. (1403). 'چالش‌ها و موانع واکسیناسیون ویروس پاپیلومای انسانی در زنان سنین باروری بر مبنای مدل اعتقاد بهداشتی؛ مروری سیستماتیک', , 27(8), pp. 64-80. doi: 10.22038/ijogi.2024.79736.6083
علیزاده, لیلا, کشاورز, دکتر زهره, شالباف, دکتر احمد, ایرانپور, دکتر سهراب. چالش‌ها و موانع واکسیناسیون ویروس پاپیلومای انسانی در زنان سنین باروری بر مبنای مدل اعتقاد بهداشتی؛ مروری سیستماتیک. , 1403; 27(8): 64-80. doi: 10.22038/ijogi.2024.79736.6083

چالش‌ها و موانع واکسیناسیون ویروس پاپیلومای انسانی در زنان سنین باروری بر مبنای مدل اعتقاد بهداشتی؛ مروری سیستماتیک

مجله زنان، مامایی و نازایی ایران
دوره 27، شماره 8، آبان 1403، صفحه 64-80    اصل مقاله (852.43 K)
نوع مقاله: مروری
شناسه دیجیتال (DOI): 10.22038/ijogi.2024.79736.6083
نویسندگان
لیلا علیزاده1؛ دکتر زهره کشاورز* 2؛ دکتر احمد شالباف3؛ دکتر سهراب ایرانپور4
1دانشجوی دکتری تخصصی بهداشت باروری، کمیته تحقیقات و فناوری دانشجویی، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران.
2استاد گروه مامایی و بهداشت باروری، دانشکده پرستاری و مامایی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران.
3دانشیار، گروه فیزیک و مهندسی پزشکی، دانشکده پزشکی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران.
4استادیار گروه پزشکی اجتماعی، دانشکده پزشکی، دانشگاه علوم پزشکی اردبیل، اردبیل، ایران.
چکیده
مقدمه: ویروس پاپیلومای انسانی (HPV)، مهم‌ترین عامل آغازگر ابتلاء به سرطان دهانه رحم و مرگ ومیر ناشی از آن می ­باشد. علی‌رغم اثربخشی قابل توجه واکسن HPV در پیشگیری از این سرطان، میزان واکسیناسیون در بسیاری از جوامع همچنان پایین می­ باشد؛ مطالعه حاضر با هدف مرور چالش‌ها و موانع واکسیناسیون بر مبنای مدل اعتقاد بهداشتی در زنان سنین باروری انجام شد.
روش‌کار: در این مطالعه مروری، پایگاه‌های اطلاعاتی معتبر توسط دو محقق مستقل، طبق دستورالعمل PICO و با استفاده از واژه­های کلیدی Mesh شامل: Papillomavirus Infections، Human papillomavirus، Papillomavirus Vaccines، Health Belief Model، Self-Care، Patient Participation،Health Education، needs assessment و women مورد جستجو قرار گرفتند. روند انتخاب مقالات بر اساس پریسما و ارزیابی کیفیت مقالات برمبنای چک‌لیست NOS و CASP صورت گرفت.
یافته ­ها: بعد از بررسی و ارزیابی کیفی 2258 مقاله، 13 مقاله با 19061 مشارکت کننده زن وارد مرور یکپارچه شدند. بر اساس نتایج؛ چالش­ ها و موانع درک شده در سه گروه عمده فردی، روانی - اجتماعی و سازمانی قرار گرفت. مهم‌ترین موانع فردی، اطلاعات کم و یا غلط در مورد ویروس و آسیب‌ناپذیری درک شده در برابر بیماری‌زایی آن بوده و مهم‌ترین موانع روانی- اجتماعی، ترس و شرم زنان و تابو بودن بیماری‌های منتقله جنسی در جامعه بود. عدم دسترسی آسان به واکسن HPV، عدم برقراری ارتباط مؤثر توسط مراقبین سلامت و وجود شکاف‌های ارتباطی و مراقبتی نیز از عمده‌ترین موانع سازمانی بودند.
نتیجه ­گیری: طبق نتایج این مطالعه، استراتژی­ های راهبردی از جمله ارتقاء دانش افراد در زمینه HPV، ارائه خدمات مشاوره جنسی و واکسیناسیون روتین و رایگان HPV بایستی در الویت سیاست‌گذاری‌ها و برنامه‌ریزی ­های حوزه بهداشت جنسی قرار گرفته و توانمندسازی مراقبین سلامت در جهت برقراری ارتباط مؤثر و مداوم با مددجویان مدنظر قرار گیرد.
کلیدواژه‌ها
سرطان دهانه رحم؛ مدل اعتقاد بهداشتی؛ واکسن ویروس پاپیلومای انسانی؛ ویروس پاپیلومای انسانی
مراجع
  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2021; 71(3):209-49.
  2. Human papillomavirus (HPV) and cervical cancer 2019 [cited 2018 September 21] [Internet]. Available from: https://www.who.int/en/ news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer.
  3. World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention; 2021.
  4. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. 2nd Geneva: World Health Organization; 2014. Preface. Available from: https://www.ncbi.nlm.nih.gov/books/NBK269613/
  5. Liu B, Taioli E. Associations between human papillomavirus and history of cancer among US adults in the National Health and Nutrition Examination Survey (2003–2010). British journal of cancer 2014; 111(7):1448-53.
  6. Gross G. Genitoanal human papillomavirus infection and associated neoplasias. InHuman Papillomavirus 2014; 45:98-122.
  7. Zhang R, Shi TY, Ren Y, Lu H, Wei ZH, Hou WJ, et al. Risk factors for human papillomavirus infection in Shanghai suburbs: a population-based study with 10,000 women. Journal of Clinical Virology 2013; 58(1):144-8.
  8. Wu J, Xiao F, Zheng Y, Lin Y, Wang HL. Worldwide trend in human papillomavirus–attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030. Cancer 2021; 127(17):3172-82.
  9. Gargano J, Meites E, Watson M, Unger E, Markowitz L, Background I. Manual for the surveillance of vaccine-preventable diseases. Centers for Disease Control and Prevention. 2017.
  10. Becker ER, Shegog R, Savas LS, Frost EL, Coan SP, Healy CM, et al. Parents’ Experience with a Mobile Health Intervention to Influence Human Papillomavirus Vaccination Decision Making: Mixed Methods Study. JMIR Pediatrics and Parenting 2022; 5(1):e30340.
  11. Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics 2016; 137(3).
  12. Markowitz LE, Gee J, Chesson H, Stokley S. Ten years of human papillomavirus vaccination in the United States. Academic pediatrics 2018; 18(2):S3-10.
  13. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008; 113(S10):3036-46.
  14. Printz C. FDA approves Gardasil 9 for more types of HPV. Cancer 2015; 121(8):1156-7.
  15. Hasanzadeh Mofrad M, Jedi L, Ahmadi S. The role of human papilloma virus (HPV) vaccines in prevention of Cervical Cancer, review article. The Iranian Journal of Obstetrics, Gynecology and Infertility 2016; 19(21):22-9.
  16. World Health Organization. WHO updates recommendations on HPV vaccination schedule. WHO, 2022 [cited Jul 18, 2023].
  17. Yarmohammadi S, Ghaffari M, Mashayekhi P, Ramezankhani A, Mirzaei J. Strategies for improving participation in human papillomavirus vaccination among young adults in the capital of Iran: a qualitative–exploratory study. International Journal of Preventive Medicine 2022; 13(1):1.
  18. Farzaneh E, Heydari H, Shekarchi AA, Kamran A. Breast and cervical cancer-screening uptake among females in Ardabil, northwest Iran: a community-based study. OncoTargets and therapy 2017: 985-92.
  19. Smith DL, Perkins RB. Low rates of HPV vaccination and cervical cancer screening: Challenges and opportunities in the context of the COVID-19 pandemic. Preventive Medicine 2022; 159:107070.
  20. Mohammad Z, Ahmad N, Baharom A. The effects of theory-based educational intervention and WhatsApp follow-up on papanicolaou smear uptake among postnatal women in Malaysia: Randomized controlled trial. JMIR mHealth and uHealth 2022; 10(6):e32089.
  21. Si M, Su X, Jiang Y, Qiao Y, Liu Y. Interventions to improve human papillomavirus vaccination among Chinese female college students: study protocol for a randomized controlled trial. BMC Public Health 2019; 19:1-10.
  22. Haddad SF, Kerbage A, Eid R, Kourie HR. Awareness about the human papillomavirus (HPV) and HPV vaccine among medical students in Lebanon. Journal of Medical Virology 2022; 94(6):2796-801.
  23. Trucchi C, Restivo V, Amicizia D, Fortunato F, Manca A, Martinelli D, et al. Italian health care workers’ knowledge, attitudes, and practices regarding human papillomavirus infection and prevention. International journal of environmental research and public health 2020; 17(15):5278.
  24. Icardi G, Costantino C, Guido M, Zizza A, Restivo V, Amicizia D, et al. Burden and prevention of HPV. knowledge, practices and attitude assessment among pre-adolescents and their parents in Italy. Current pharmaceutical design 2020; 26(3):326-42.
  25. Widjaja VN. Awareness, knowledge and attitudes of human papillomavirus (HPV) among private university students-Malaysia perspective. Asian Pacific Journal of Cancer Prevention: APJCP 2019; 20(7):2045.
  26. Taebi M, Riazi H, Keshavarz Z, Afrakhteh M. Knowledge and attitude toward human papillomavirus and HPV vaccination in Iranian population: a systematic review. Asian Pacific journal of cancer prevention: APJCP 2019; 20(7):1945.
  27. Fakor F, Mahfouzi L, Dalil Heirati SF, Graili S. Knowledge and attitudes of medical students about human papilloma virus (HPV) vaccination and associated factors. Journal of Holistic Nursing And Midwifery 2016; 26(4):71-9.
  28. Huchko MJ, Saduma I, Blat C, Oketch S, Bukusi EA. How providing cervical cancer screening results via cell phone affects patient follow-up rates in western Kenya. Journal of Global Oncology 2019; 5:1-8.
  29. Sanchez Antelo V, Szwarc L, Paolino M, Saimovici D, Massaccesi S, Viswanath K, et al. A counseling mobile app to reduce the psychosocial impact of human papillomavirus testing: formative research using a user-centered design approach in a low-middle-income setting in Argentina. JMIR Formative Research 2022; 6(1):e32610.
  30. Janz NK, Champion VL, Strecher VJ. The Health Belief Model. In Glanz K, Rimer BK, Lewis FM (Eds.), Health behavior and health education: Theory, research, and practice. 3nd Jossey-Bass. San Francisco, CA; 2002.
  31. Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC medical research methodology 2014; 14:1-5.
  32. Critical Appraisal Skills Programme (CASP). CASP Checklists 2021. Available online: https://casp-uk.net/casp-tools-checklists/.
  33. Adegboyega A, Obielodan O, Wiggins AT, Dignan M, Williams LB. Beliefs and knowledge related to human papillomavirus (HPV) vaccine among African Americans and African immigrants young adults. Cancer Causes & Control 2023; 34(5):479-89.
  34. Galeshi M, Shirafkan H, Yazdani S, Motaghi Z. Challenges and needs of HPV-positive women. INQUIRY: The Journal of Health Care Organization, Provision, and Financing 2023; 60:00469580221150094.
  35. Nkwonta CA, Dawson RM, Adegboyega A. “I don’t think I have a chance to get it”: International university student HPV knowledge and preventive behaviors. Journal of American College Health 2022; 70(1):240-7.
  36. Qaderi K, Mirmolaei ST, Geranmayeh M, Sheikh Hasani S, Farnam F. Iranian women’s psychological responses to positive HPV test result: a qualitative study. BMC Women's Health 2021; 21:1-11.
  37. Symmons SM, Waller J, McBride E. Testing positive for Human Papillomavirus (HPV) at primary HPV cervical screening: a qualitative exploration of women’s information needs and preferences for communication of results. Preventive Medicine Reports 2021; 24:101529.
  38. Qaderi K, Germmaych M, Mirmolaci ST, Farnam F, Hasani SS. “Nothing Is Like Before”: Iranian Women with Human Papillomavirus' Sexual Life. The Journal for Nurse Practitioners 2021; 17(10):1261-6.
  39. Freijomil-Vázquez C, Gastaldo D, Coronado C, Movilla-Fernández MJ. Health care informational challenges for women diagnosed with cervical intraepithelial neoplasia: a qualitative study. BMC women's health 2019; 19:1-10.
  40. Dalle Fratte CF, Passerini A, Vivori C, Dalla Palma P, Guarrera GM. The relevance of citizen involvement in Health Technology Assessment. A concrete application in the assessment of HPV co-testing in the Autonomous Province of Trento. Epidemiology, Biostatistics, and Public Health 2015; 12(3).
  41. Shao X, Lu X, Zhou W, Huang W, Lu Y. HPV vaccination behavior, vaccine preference, and health beliefs in Chinese female health care workers: a nationwide cross-sectional study. Vaccines 2023; 11(8):1367.
  42. Alsous MM, Ali AA, Al-Azzam SI, Abdel Jalil MH, Al-Obaidi HJ, Al-Abbadi EI, et al. Knowledge and awareness about human papillomavirus infection and its vaccination among women in Arab communities. Scientific reports 2021; 11(1):786.
  43. McBride KR, Singh S. Predictors of adults’ knowledge and awareness of HPV, HPV-associated cancers, and the HPV vaccine: implications for health education. Health Education & Behavior 2018; 45(1):68-76.
  44. Kim J. The relationship of health beliefs with information sources and HPV vaccine acceptance among young adults in Korea. International journal of environmental research and public health 2018; 15(4):673.
  45. Moreira ED, Oliveira BG, Ferraz FM, Costa S, Costa Filho JO, Karic G. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention. International Journal of Gynecologic Cancer 2006; 16(2).
  46. Taylor CA, Keller ML, Egan JJ. Advice from affected persons about living with human papillomavirus infection. Image: the Journal of Nursing Scholarship 1997; 29(1):27-32.
  47. Salehifar D, Lotfi R, Akbari Kamrani M. Knowledge about cervical cancer, human papilloma virus and attitude towards acceptance of vaccination among female students. Payesh 2015; 14(2):217-226.
  48. Beltran R, Simms T, Lee HY, Kwon M. HPV literacy and associated factors among Hmong American immigrants: Implications for reducing cervical cancer disparity. Journal of community health 2016; 41:603-11.
  49. Thanasas I, Lavranos G, Gkogkou P, Paraskevis D. The effect of health education on adolescents’ awareness of HPV infections and attitudes towards HPV vaccination in Greece. International Journal of Environmental Research and Public Health 2022; 19(1):503.
  50. Zur Hausen H. Papillomavirus infections—a major cause of human cancers. Biochimica et biophysica acta (BBA)-reviews on cancer 1996; 1288(2):F55-78.
  51. Kasamatsu E, Rodriguez Riveros MI, Soilan AM, Ortega M, Mongelos P, Paez M, et al. Factors associated with high-risk human papillomavirus infection and high-grade cervical neoplasia: A population-based study in Paraguay. PLoS One 2019; 14(6):e0218016.
  52. Ampofo AG, Boyes AW, Asibey SO, Oldmeadow C, Mackenzie LJ. Prevalence and correlates of modifiable risk factors for cervical cancer and HPV infection among senior high school students in Ghana: a latent class analysis. BMC Public Health 2023; 23(1):340.
  53. Yang D, Zhang J, Cui X, Ma J, Wang C, Piao H. Risk factors associated with human papillomavirus infection, cervical cancer, and precancerous lesions in large-scale population screening. Frontiers in Microbiology 2022; 13:914516.
  54. Omrani-Navai V, Alizadeh-Navaei R, Yahyapour Y, Hedayatizadeh-Omran A, Abediankenari S, Janbabaei G, et al. Human papillomavirus and gastrointestinal cancer in Iranian population: A systematic review and meta-analysis. Caspian journal of internal medicine 2017; 8(2):67.
  55. Szydlowski J, Jonczyk-Potoczna K, Pucher B, Buraczynska-Andrzejewska B, Prauzinska M, Kolasinska-Lipinska J, et al. Prevalence of human papillomavirus (HPV) in upper respiratory tract mucosa in a group of pre-school children. Annals of Agricultural and Environmental Medicine 2014; 21(4).
  56. Touch S, Oh JK. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia. BMC cancer 2018; 18:1-8.
  57. Osowiecka K, Yahuza S, Szwiec M, Gwara A, Kasprzycka K, Godawska M, et al. Students’ knowledge about cervical cancer prevention in Poland. Medicina 2021; 57(10):1045.
  58. Pourkazemi A, Ghanbari A, Fakour F, Ghorbani S. Knowledge and Attitudes of Medical Students Toward Human Papilloma Virus in Rasht 2013. JGUMS 2017; 25(100):1-10.
  59. Sherman SM, Bartholomew K, Denison HJ, Patel H, Moss EL, Douwes J, et al. Knowledge, attitudes and awareness of the human papillomavirus among health professionals in New Zealand. PloS one 2018; 13(12):e0197648.
  60. Sherman SM, Cohen CR, Denison HJ, Bromhead C, Patel H. A survey of knowledge, attitudes and awareness of the human papillomavirus among healthcare professionals across the UK. European Journal of Public Health 2020; 30(1):10-6.
  61. Badgujar VB, Ahmad Fadzil FS, Balbir Singh HK, Sami F, Badgujar S, Ansari MT. Knowledge, understanding, attitude, perception and views on HPV infection and vaccination among health care students and professionals in Malaysia. Human vaccines & immunotherapeutics 2019; 15(1):156-62.
  62. Gopalani SV, Sedani AE, Janitz AE, Clifton SC, Peck JD, Comiford A, et al. Barriers and factors associated with HPV vaccination among American Indians and Alaska Natives: a systematic review. Journal of community health 2022; 47(3):563-75.
  63. Marlow LA, Waller J, Wardle J. Barriers to cervical cancer screening among ethnic minority women: a qualitative study. Journal of Family Planning and Reproductive Health Care 2015; 41(4):248-54.
  64. Waller J, Marlow LA, Wardle J. The association between knowledge of HPV and feelings of stigma, shame and anxiety. Sexually transmitted infections 2007; 83(2):155-9.
  65. Palencia-Sánchez F, Echeverry-Coral SJ. Social considerations affecting acceptance of HPV vaccination in Colombia. A systematic review. Revista Colombiana de Obstetricia y Ginecología 2020; 71(2):178-94.
  66. Alizadeh L, Ghahremani F, Khalili SM, Havaei M, Hajirafiei E, Riazi H, et al. The association of human papillomavirus vaccine with premature ovarian failure: a systematic review. The Iranian Journal of Obstetrics, Gynecology and Infertility 2023; 25(12):114-23.
  67. Ogwunga CC, Anyadoh-Nwadike SO, Ahumibe NC, Nwakwasi EU. Knowledge and attitude of female students of tertiary institutions in Imo State, Nigeria towards cervical cancer and its screening. Journal of Community Health 2021; 46:509-14.
  68. Filiberti A, Tamburini M, Stefanon B, Merola M, Bandieramonte G, Ventafridda V, et al. Psychological aspects of genital human papillomavirus infection: a preliminary report. Journal of Psychosomatic Obstetrics & Gynecology 1993; 14(2):145-52.
  69. Bazan SB, de Alencar Muniz Chaves A, Aires KA, Cianciarullo AM, Garcea RL, Ho PL. Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris. Archives of virology 2009; 154:1609-17.
  70. Benyo S, Keane A, Warrick J, Choi KY. HPV‐positive oral papillomas in an adolescent—A diagnostic dilemma. Clinical Case Reports 2021; 9(8):e04546.
  71. Bezold G, Politch JA, Kiviat NB, Kuypers JM, Wolff H, Anderson DJ. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertility and sterility 2007; 87(5):1087-97.
  72. Hufbauer M, Wieland U, Gebel J, Steinmann J, Akgül B, Eggers M. Inactivation of polyomavirus SV40 as surrogate for human papillomaviruses by chemical disinfectants. Viruses 2021; 13(11):2207.
  73. Galeshi M, Shirafkan H, Yazdani S, Motaghi Z. Reproductive health needs of Human papillomavirus (HPV) positive women: A systematic review. Plos one 2022; 17(9):e0266819.
  74. Mojarad FA, Khani S, Aliabadian A, Purbarar F, Yaghoubi T. The exploration of life experience of married people with genital warts: A qualitative study. Journal of Nursing and Midwifery Sciences 2022; 9(2):96-104.
  75. Mortensen GL, Larsen HK. The quality of life of patients with genital warts: a qualitative study. BMC Public Health 2010; 10:1-8.
  76. Verhoeven V, Baay MF, Baay PE, Lardon F, Van Royen P, Vermorken JB. Everything you always wanted to know about HPV (but could not ask your doctor). Patient education and counseling 2010; 81(1):101-5.
  77. Allen-Leigh B, Uribe-Zúñiga P, León-Maldonado L, Brown BJ, Lörincz A, Salmeron J, et al. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study. BMC cancer 2017; 17:1-11.
  78. Khatibi M, Rasekh HR, Shahverdi Z. Cost-effectiveness evaluation of quadrivalent human papilloma virus vaccine for HPV-related disease in Iran. Iranian journal of pharmaceutical research: IJPR 2014; 13(Suppl):225.
  79. Tatari CR, Andersen B, Brogaard T, Badre-Esfahani SK, Jaafar N, Kirkegaard P. Perceptions about cancer and barriers towards cancer screening among ethnic minority women in a deprived area in Denmark–a qualitative study. BMC Public Health 2020; 20:1-10.
آمار
تعداد مشاهده مقاله: 1,020
تعداد دریافت فایل اصل مقاله: 552